Navigation Links
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Date:11/2/2007

in clinical trials were fatigue/asthenia (65%), headache (43%), pyrexia (41%), myalgia (40%), irritability/anxiety/nervousness (33%), insomnia (30%), alopecia (28%), neutropenia (27%), nausea/vomiting (25%), rigors (25%), anorexia (24%), injection site reaction (23%), arthralgia (22%), depression (20%), pruritus (19%) and dermatitis (16%).

Serious adverse events in hepatitis C trials included neuropsychiatric disorders (homicidal ideation, suicidal ideation, suicide attempt, suicide, psychotic disorder and hallucinations), serious and severe bacterial infections (sepsis), bone marrow toxicity (cytopenia and rarely, aplastic anemia), cardiovascular disorders (hypertension, supraventricular arrhythmias and myocardial infarction), hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, psoriasis, lupus, rheumatoid arthritis and interstitial nephritis), pulmonary disorders (dyspnea, pneumonia, bronchiolitis obliterans, interstitial pneumonitis and sarcoidosis), colitis (ulcerative and hemorrhagic/ischemic colitis), pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular edema and retinal thrombosis/hemorrhages, optic neuritis and papilledema). Adverse reactions reported during post-approval use of PEGASYS therapy, with and without ribavirin, include hearing impairment, hearing loss, serious skin reactions, including erythema multiforme major, and infections (bacterial, viral and fungal).

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that ad
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/h85dj3/pharmaceutical ) has ... by Packaging Type, by Raw Material, by Drug Delivery ... to 2020" report to their offering. ... estimated to reach above $80 Billion by 2020 ... a steady growth rate in the coming years. Drug ...
(Date:7/29/2015)... York , July 29, 2015 ... Transparency Market Research " Active Pharmaceutical Ingredients (API) Market ... Forecast 2014 - 2020 " the global active pharmaceutical ... 2013 and is anticipated to reach USD 185.9 billion ... the forecast period from 2014 to 2020. ...
(Date:7/29/2015)... Fla. , July 29, 2015 ... of Azelastine HCl Nasal Solution, 0.1%. The U.S. Food ... New Drug Application (ANDA), which is AB rated ... Azelastine hydrochloride nasal solution (nasal spray) is a ... 2015 IMS Health sales data.  Azelastine HCl Nasal ...
Breaking Medicine Technology:Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 2Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 2Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 4Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 5
(Date:7/29/2015)... ... July 29, 2015 , ... VideoLink , ... Medical Center, located in New York, NY, selected the ReadyCam on-site video studio ... and scientists to immediately access worldwide TV and cable news networks and participate ...
(Date:7/29/2015)... ... July 29, 2015 , ... The federal government and business ... substance abuse is having on lost productivity, workplace accidents and injuries, employee absenteeism, ... year. [1] Will Wesch, Director of Admissions for Novus Medical Detox Center ...
(Date:7/29/2015)... ... July 29, 2015 , ... Today the nonprofit ... Prevention through Vaccination in Older Adults, that provides a comprehensive overview of the ... government, and health care experts can improve patient compliance. , Although influenza, pneumococcal, ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Potomac Pilates, ... rebrand, changing its name to Rock the Reformer ® by Potomac Pilates. On ... http://www.RockTheReformer.com . Rock the Reformer ® by Potomac Pilates will continue to offer ...
(Date:7/29/2015)... ... 29, 2015 , ... The report “Atherosclerosis - Pipeline Review, ... a slow, progressive disease that may start in childhood. The report strengthens R&D ... Complete report on Atherosclerosis Pipeline with 78 market data tables and 15 figures, ...
Breaking Medicine News(10 mins):Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4
... 14k gold pendants intended to ... reframe the perception of infertility., APPLETON, Wis., Oct. ... Medals, LLC has introduced the Fertility,Hope(C) pendant created for these ... 14k gold pendants feature a,heart within a spiral surrounded by ...
... & Montague,("Berger") announced today that a class action lawsuit ... York on behalf of all purchasers of,American Depository Shares ... or the "Company") and all purchasers of,options to purchase ... July 29, 2008 (the "Class Period") charging Elan and ...
... Drive Company,s Latest Learning Technology, ORLANDO, Fla., ... a leading provider of educational enterprise technology,announced today ... Release 9.0,featuring nearly 50 institutions that are now ... of the Beta program are evaluating and providing ...
... 29 Amidst the din of modern society, the,most ... is the,message that rings loud and clear in "Do ... a practical guide to loving,one,s authentic self by Carmen ... full of fancy words and complex concepts to sit,on ...
... 65 and older, study says , , TUESDAY, Oct. 28 (HealthDay ... an added boost to the immune system of people aged ... to a U.S. study that included nearly 4,000 people. , ... times greater than the standard flu vaccine had 30 percent ...
... Himes and,Rep. Chris Shays, candidates for US House of ... support a comprehensive,strategy to fight HIV/AIDS in the US ... are HIV-positive, and in 2006 there,were 422 new cases, ... for Disease Control. Approximately 56,000 people are infected with,HIV ...
Cached Medicine News:Health News:Infertility Survivor Creates Symbolic Pendant to Honor the Journey. 2Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 2Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 3Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 4Health News:Blackboard Announces Launch of Beta Program 2Health News:Blackboard Announces Launch of Beta Program 3Health News:Blackboard Announces Launch of Beta Program 4Health News:A Different Way of Thinking for a Fulfilling Life: New Book Offers Practical Guidance for Rethinking Happiness and Nurturing Self-Love 2Health News:High-Dose Flu Shot Benefits Elderly 2Health News:House Candidates Jim Himes and Chris Shays Pledge Action on HIV/AIDS Epidemic 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: